SCHEMBL7614425

SCHEMBL7614425

OCC(c1cccc(Br)c1)c1ccccn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 4/20 0.46
SLC6A4 P31645 4/20 0.46
SLC6A3 Q01959 3/20 0.46
CHRM2 P08172 3/20 0.45
CHRM1 P11229 2/20 0.45
DRD1 P21728 2/20 0.45
HRH1 P35367 2/20 0.45
KCNH2 Q12809 2/20 0.45
HRH3 Q9Y5N1 2/20 0.45
SCN1A P35498 2/20 0.45
SCN2A Q99250 2/20 0.45
SCN3A Q9NY46 2/20 0.45
LMNA P02545 2/20 0.45
CYP2D6 P10635 1/20 0.45
NFKB1 P19838 1/20 0.45
THPO P40225 1/20 0.45
HIF1A Q16665 1/20 0.45
HTR2C P28335 1/20 0.45
ADRA2B P18089 1/20 0.45
HTR2A P28223 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11599476 0.84 SLC6A2 (0.59) SLC6A2SLC6A4SLC6A3CHRM2CHRM1
SCHEMBL25219221 0.82 SLC6A2 (0.47) SLC6A2SLC6A4SLC6A3CHRM2CHRM1
SCHEMBL17295946 0.80 IDO1 (0.49) HTR2AALDH1A1IDO1TDO2KDM4E
SCHEMBL7605334 0.80 IDO1 (0.47) SLC6A2SLC6A4SLC6A3KCNH2CYP2D6
SCHEMBL11968461 0.80 SLC6A2 (0.46) SLC6A2SLC6A4SLC6A3CHRM2CHRM1
SCHEMBL6268312 0.75 SLC6A2 (0.42) SLC6A2SLC6A4SLC6A3CHRM2CHRM1
SCHEMBL9530814 0.73 SLC6A2 (0.46) SLC6A2SLC6A4SLC6A3CHRM2CHRM1
SCHEMBL5949434 0.70 GRIN2D (0.47) SLC6A4CYP2D6ALDH1A1CYP1A2CYP3A4
SCHEMBL16915442 0.69 SLC6A2 (0.44) SLC6A2SLC6A4SLC6A3CHRM2KCNH2
SCHEMBL9186509 0.69 SLC6A2 (0.63) SLC6A2SLC6A4SLC6A3CHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020035123-A1 New substituted pyridine or piperidine compounds ADIR ET COMPAGNIE 2002-03-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020035123-A1 New substituted pyridine or piperidine compounds OPRD1, CNR1, HRH4 SLC6A2 2824/4885SLC6A4 2045/4885SLC6A3 2857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.